Unicycive Therapeutics, Inc. (UNCY)
5.20
-0.06
(-1.23%)
USD |
NASDAQ |
Aug 31, 16:00
5.22
+0.02
(+0.38%)
After-Hours: 20:00
Unicycive Therapeutics Cash from Operations (TTM) : -27.84M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -27.84M |
| March 31, 2026 | -28.66M |
| December 31, 2025 | -31.32M |
| September 30, 2025 | -29.83M |
| June 30, 2025 | -33.12M |
| March 31, 2025 | -31.02M |
| December 31, 2024 | -28.58M |
| September 30, 2024 | -26.47M |
| June 30, 2024 | -21.64M |
| March 31, 2024 | -20.82M |
| December 31, 2023 | -18.28M |
| September 30, 2023 | -19.93M |
| Date | Value |
|---|---|
| June 30, 2023 | -19.07M |
| March 31, 2023 | -16.61M |
| December 31, 2022 | -15.65M |
| September 30, 2022 | -10.97M |
| June 30, 2022 | -10.88M |
| March 31, 2022 | -8.051M |
| December 31, 2021 | -5.767M |
| September 30, 2021 | -4.902M |
| June 30, 2021 | -2.134M |
| March 31, 2021 | -2.059M |
| December 31, 2020 | -1.459M |
| September 30, 2020 | -1.37M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Theriva Biologics, Inc. | -12.74M |
| AbbVie, Inc. | 19.51B |
| Decoy Therapeutics, Inc. | -8.324M |
| Nkarta, Inc. | -92.76M |